US Medical Franchise Head, Rheumatology

Job Title: US Medical Franchise Head, Rheumatology

Location: Remote

About the Job

Lead the Rheumatology, US Medical Immunology team, as a valued strategic partner with Clinical, Commercial, Regulatory and Market Access to bring innovative therapeutic solutions to improve the lives of patients and establish Sanofi as a leader in Immunology.   

The US Medical Franchise Head, Rheumatology is responsible for orchestrating the seamless integration of the medical capabilities to deliver comprehensive solutions that address the holistic needs of customers and patients.  This leader is responsible for developing the U.S. medical strategy and tactical plan for their entire Therapeutic Area, the MSL Field strategy/leadership and operations to ensure delivery.  This includes a strong partnership with global, alliance management and the relevant U.S. cross-functional partners and ensuring these plans are tailored to the local needs and resources, both on data generation and all aspects of engagement with the scientific community.   

We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main Responsibilities: 

• Provide leadership to the Rheumatology, US Medical Immunology team (Medical Directors, Medical Science Liaison Managers, MSLs & Medical Operations Manager) by cultivating a culture of teamwork and collaboration to ensure the delivery of key priorities, while attracting, developing and retaining top talent.  

• In collaboration with Global and Alliance Medical partners, be accountable and lead the development of an Integrated Medical Plan (MSLs, IME, Medical Communications and Publications, Health outcomes, Safety and Clinical Research (phase IIIB-IV and ISTs)) and annual budget for the respective Therapeutic Area.  

• Lead and monitor the execution of the Integrated Medical Plan to ensure on-time and on-budget delivery of all tactical activities or deliverables.  

• Communicate the details and progress of the Medical Plan to Senior Management, the Core Team and all parties responsible for execution.  

• Ensure strategic and cross-functional alignment across the organization and any joint ventures to achieve the medical mission of supporting safe and appropriate use of our products – including the alignment across the US Immunology franchise. 

• Support the generation and communication of scientific and medical insights to internal stakeholders, develop/execute strategic and tactical Medical Engagement Plans, and manage MSL resources and budgets.  

• Partner with Regional Medical Head, Medical Directors, and other internal partners to manage high-level regional stakeholder relationships, contribute to medical engagement planning, and oversee the MSL budget.  

• Identify and support MSL managers on opportunities for innovation and field excellence initiatives to differentiate Sanofi medical and help achieve and exceed department objectives.  

• Aligns MSL roles and responsibilities across internal and external stakeholders, ensuring they align with country launch plans and global policies.  

• Analyzes data to optimize resources and support MSL field force planning for product life cycles, including pre-launch.  

• Collaborates with internal stakeholders, shares best practices across geographies, and ensures MSL objectives and KPIs are tracked.  

• Develops recruiting plans and responsible to recruit, hire, develop, and manage medical talent, and secures approval for headcount changes to support the MSL & HO team’s needs.  

• Provide medical leadership and expertise to sales, marketing, legal and regulatory functions for marketed products and drugs in development